BioSpace News Archive

PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, today reported its financial results for the third quarter ended September 30, 2021.

Dyadic International, Inc. today announced that it will report its financial results for the third quarter ended September 30, 2021 and host a corporate update conference call on Wednesday, November 10, 2021.

TYME Technologies, Inc. today announced that the Company will report its second quarter 2022 financial results on Monday, November 8, 2021 at 8:30 AM ET.

Innovent Biologics, Inc. and NeoCura Bio-Medical Technology Co., Ltd. jointly announced that they have entered into a strategic collaboration agreement to carry out a clinical study in China on the combination therapy of sintilimab from Innovent and individualized neoantigen vaccine NEO_PLIN2101 from NeoCura.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced that its wholly owned subsidiary, APR Applied Pharma Research SA, reported positive interim results from its clinical trial of nasal spray Sentinox in SARS-CoV-2 infected patients, confirming its safety and tolerability.

Infection control using various sterilization techniques form a part of all healthcare settings.

Rising geriatric population, coupled with the rapid increase in the incidence of various chronic diseases are favouring the upward trajectory of the global medical clothing market.

The clinical risk grouping solutions market is anticipated to observe steady growth during the forecast period of 2021-2031.

A cataract is an ocular disease in which the lens of an individual’s eye degrades progressively and turns opaque, resulting in blurred vision.

5G is a widely popular nomenclature for the emerging and fifth generation of mobile and telecommunications technology.